透云生物(01332)发布年度业绩,股东应占亏损8810.7万港元 同比减少67.24%

智通财经
26 Mar

智通财经APP讯,透云生物(01332)发布截至2024年12月31日止年度业绩,该集团取得销售所提供货品及服务的收入1.52亿港元,同比减少23.09%;公司拥有人应占亏损8810.7万港元,同比减少67.24%;每股亏损3.14港仙。

公告称,亏损减少主要乃因按公平值计入损益的非持作买卖金融资产的公平值亏损减少;及物业、厂房及设备以及使用权资产减值减少。物业、厂房及设备以及使用权资产减值属非现金项目,不影响本集团营运的现金流量。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10